Suppr超能文献

早期口咽癌患者调强放射治疗后腮腺体积变化的前瞻性研究:一项机构经验。

Prospective study of sequential volumetric changes of parotid gland in early oropharyngeal carcinoma patients treated by intensity-modulated radiation therapy: An institutional experience.

作者信息

Patel Pooja Nandwani, Goyal Sumit, Shah Anand, Gohel Mehul, Suryanarayana Unnikrishnan

机构信息

Department of Radiotherapy, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.

Department of Community Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.

出版信息

South Asian J Cancer. 2018 Jan-Mar;7(1):55-57. doi: 10.4103/sajc.sajc_183_17.

Abstract

AIMS AND OBJECTIVES

During course of radiation therapy, anatomical variations occur risking overdose of parotid gland. We tried to quantify volume of parotid gland and mean dose to parotid gland after every 10 fractions (#).

MATERIALS AND METHODS

We conducted the prospective study from July 2016 to May 2017 in 25 patients of early-stage oropharyngeal carcinoma. Patients had Karnofsy Performance Score of 80-100, median age was 54 years, and 18 patients were males. Patients were planned with intensity-modulated radiation therapy planning with dose as 66 Gy/30# to planning target volume (PTV) including primary and 54 Gy/30# to PTV-nodal including elective neck irradiation. After each 10#, replanning was done, and variations in parotid volume were studied including D (mean dose to parotids) and D (the dose delivered to 50% of volume). Other tumor characteristic like PTV of primary was also assessed and minimum PTV volume covered by 95% isodose line was kept as 95%.

RESULTS

Average parotid volumes decreased by the mean value of 10% and 6% for the left and right parotids, respectively, and PTV of primary target decreased by mean of 13%. The difference in D doses to parotid glands was 32% and 42% and difference in D dose was 30% and 35% on the left and right side, respectively.

CONCLUSIONS

The parotid volumes differ considerably during adaptive planning done after every ten fractions. These differences in parotid volumes and doses received to parotid glands play a significant role in the risk of xerostomia observed during later follow-up.

摘要

目的

在放射治疗过程中,解剖结构会发生变化,存在腮腺过量照射的风险。我们试图量化腮腺体积以及每10次分割照射(#)后腮腺的平均剂量。

材料与方法

2016年7月至2017年5月,我们对25例早期口咽癌患者进行了前瞻性研究。患者的卡氏评分在80 - 100分之间,中位年龄为54岁,其中18例为男性。患者采用调强放射治疗计划,计划靶区(PTV)包括原发灶的剂量为66 Gy/30#,包括选择性颈部照射的PTV-淋巴结剂量为54 Gy/30#。每10次分割照射后进行重新计划,并研究腮腺体积的变化,包括D(腮腺平均剂量)和D(50%体积所接受的剂量)。还评估了其他肿瘤特征,如原发灶的PTV,95%等剂量线覆盖的最小PTV体积保持为95%。

结果

左、右腮腺的平均体积分别下降了10%和6%,原发靶区的PTV平均下降了13%。左侧和右侧腮腺的D剂量差异分别为32%和42%,D剂量差异分别为30%和35%。

结论

在每10次分割照射后的适应性计划中,腮腺体积有显著差异。这些腮腺体积和接受剂量的差异在后期随访中观察到的口干风险中起重要作用。

相似文献

3
Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e313-9. doi: 10.1016/j.ijrobp.2011.05.005. Epub 2011 Jun 25.
4
Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
J Appl Clin Med Phys. 2018 May;19(3):251-260. doi: 10.1002/acm2.12327. Epub 2018 Apr 17.
10
Parotid gland sparing with helical tomotherapy in head-and-neck cancer.
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):443-8. doi: 10.1016/j.ijrobp.2011.11.070. Epub 2012 Jul 25.

引用本文的文献

本文引用的文献

1
Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial.
Radiother Oncol. 2013 Jan;106(1):80-4. doi: 10.1016/j.radonc.2012.10.010. Epub 2013 Jan 29.
3
Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters.
Radiother Oncol. 2012 Aug;104(2):224-9. doi: 10.1016/j.radonc.2012.06.003. Epub 2012 Jul 16.
4
Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer.
Strahlenther Onkol. 2012 Mar;188(3):243-7. doi: 10.1007/s00066-011-0041-8.
7
Adaptive replanning strategies accounting for shrinkage in head and neck IMRT.
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):924-32. doi: 10.1016/j.ijrobp.2009.04.047.
8
Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration.
Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1563-71. doi: 10.1016/j.ijrobp.2008.04.013. Epub 2008 Jun 4.
10
Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1290-6. doi: 10.1016/j.ijrobp.2007.07.2345.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验